Navigation Links
Avant’s Typhoid Fever Vaccine Demonstrates Excellent Clinical,Potential

Single-Dose Oral Ty800 Vaccine Immunogenic & Well-Tolerated in NIH-Sponsored Phase 1/2 Study

NEEDHAM, MA (May 18, 2007) - AVANT Immunotherapeutics, Inc. (Nasdaq: AVAN) announced today positive preliminary results from an investigational double-blind, placebo-controlled Phase 1/2 dose-escalating clinical trial of its typhoid fever vaccine candidate, Ty800, in healthy volunteers. The researchers found the single-dose, oral vaccine to be well tolerated and immunogenic, with over 90% of vaccinated subjects generating immune responses. Based on these excellent results, AVANT plans to further develop Ty800 to compete in the expanding typhoid fever vaccine market, which currently has over $200 million in annual sales. AVANT plans to initiate its own sponsored Phase 2 dose-ranging trial of Ty800 in mid-2007.

“Typhoid fever remains endemic in many developing areas of the world, as well as being an important potential health threat for travelers and military personnel in areas affected by the disease,” said Dr. Mitchell B. Cohen, Principal Investigator in the study and Director of Gastroenterology, Hepatology and Nutrition at Cincinnati Children’s Hospital Medical Center. “The development of an effective and practical vaccine for all ages will provide an important tool for controlling this disease. A safe typhoid fever vaccine that can be easily administered could significantly reduce the morbidity and mortality associated with typhoid fever.”

“We are delighted with these results for our single-dose, oral Ty800 vaccine candidate,” said Una S. Ryan, Ph.D., President and Chief Executive Officer of AVANT Immunotherapeutics, Inc. “These results indicate that AVANT’s vaccine may have significant potential advantages over the currently licensed vaccines, which offer limited protection rates of 50-80% and require either a single needle injection or three to four oral doses over the course o
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Avants Typhoid Fever Vaccine Demonstrates Excellent Clinical Potential
2. SIGA Passes First Hurdle with Lassa Fever Antiviral ST-193
3. Placebo-controlled Phase IIa Study with the Immunotherapeutic CYT003-QbG10 Shows Significant Improvement of Allergy Symptoms in Hay Fever Patients
4. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
5. DOR BioPharma Announces Issuance of European Patent for Its Oral Multivalent Botulinum Toxin Vaccine BT-VACC
6. From Clinical Cancer Research: Rethinking Therapeutic Cancer Vaccine Trials
7. DOR BioPharma Announces Publication Describing Results of Its Multivalent Botulinum Toxin Vaccine BT-VACC
8. Vaccine Can Prevent Cervical Cancer and Precancerous Lesions
9. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
10. Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
11. HepaLifes PBS-1 Cells for Influenza Vaccine Production Prove Superior at International Conference

Post Your Comments:
(Date:11/6/2009)...GTON, Mass., Nov. 6 DUSA...a dermatology company that is developing and marke...d other products focused on patients with common s...t and Chief Executive Officer, will present a corp...r Summit 2009 on Tuesday, November 10, 2009 at 10:...
(Date:11/6/2009)...RY, N.Y., Nov. 6 Repossessions and...ols in the third quarter of 2009 declined as compa...sau Asset Management,s NasTrac Quarterly Index (NQ...ty reports for both repossessions and orderly liqu...or both construction and printing equipment, offer...
(Date:11/6/2009)...GTON, Nov. 6 America,s ...working group of mid-market and smaller innovator ... about H.R. 3962, the "Affordable Health Care for ...hursday. These smaller companies fear that the cu...62 will hinder their efforts to bring new medicine...
Breaking Medicine Technology:NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 2NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 3NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 4Statement of America's Specialty Medicines Companies On House Health Care Bill (H.R. 3962) 2Our Communities Blood Supply Faces Summer Challenges 48116 1Our Communities Blood Supply Faces Summer Challenges 48116 2Our Communities Blood Supply Faces Summer Challenges 48116 3Latest Developments In Facelift Surgery Expert Opinion by Mr James Murphy 48114 1Latest Developments In Facelift Surgery Expert Opinion by Mr James Murphy 48114 2Latest Developments In Facelift Surgery Expert Opinion by Mr James Murphy 48114 3Death rates same for diabetes and heart disease patients receiving drug therapy or surgery 48111 1Death rates same for diabetes and heart disease patients receiving drug therapy or surgery 48111 2
...Alone and With Lipitor(R), in, Overweight or Obe...s -, HAYWARD, Calif., Sept. 25 Metabolex, Inc., ... and development of novel,therapeutics for diabete...,that it has begun a 180-patient Phase 2 trial of ... cholesterol and triglycerides to assess the drug,...
...iences, Inc., a,privately held biopharmaceutical c...ounced that it has hired industry veterans Eric D....and Deborah A. Thomas as vice president,for regula...layed an integral role in clinical,stage product p...tech,companies and leading academic cancer centers...
Other Medicine Technology:Metabolex Begins Phase 2 Trial of MBX-8025 for Treatment of Dyslipidemia 2BiPar Expands Management Team to Advance Lead PARP Inhibitor Product Candidate Into Phase 2 Trials for Cancer 2
(Date:11/6/2009)...h the number of premature births and medically fra...ye exam, including a red reflex test, should be gi...ngela Buffenn, M.D., M.P.H., Director of the Orbit...f Childrens Hospital Los Angeles. ,, "Advances ...fants to survive. Unfortunately, many of them grow...
(Date:11/6/2009)...e American Academy of Nursing today inducted seven... Williams & Wilkins (LWW) nursing publications... Health, a leading provider of information and bus...d institutions in medicine, nursing, allied health... on evidence of significant contributions to nursi...
(Date:11/6/2009)...es -- or forgetting them, researchers say , ...emember the first time you smelled a type of flowe...ggests that your brain might. , In the study, ...ology , researchers showed objects to adult study ...t or unpleasant odors and sounds. , "We found...
(Date:11/6/2009)... Forest University School of Medicine and the Univ...ome elevated prostate-specific antigen (PSA) level...ring in the body, and are not necessarily a predic...ed levels of PSA have traditionally been seen as a... widespread use of PSA testing. However, the resea...
(Date:11/6/2009)...Thermal Angel Blood & IV Fluid Infusion Warmer...Estill Medical Technologies, a family-owned Texas ...d IV Fluid Infusion Warmer , was named one of the...es at an award ceremony Wednesday. ,, Co-founde...1990, the Dallas 100(TM) identifies and recognizes...
Breaking Medicine News(10 mins):Health News:Red Reflex Vision Exam Should Be Given to All Newborns, Report Recommends 2Health News:Red Reflex Vision Exam Should Be Given to All Newborns, Report Recommends 3Health News:Seven LWW Nursing Editors Recognized as Leaders by American Academy of Nursing 2Health News:Seven LWW Nursing Editors Recognized as Leaders by American Academy of Nursing 3Health News:New Smells 'Etched' in Brain: Study 2Health News:New finding suggests prostate biopsy is not always necessary 2Health News:New finding suggests prostate biopsy is not always necessary 3Health News:Life Saving Estill Medical Technologies Receives Prestigious 'Dallas 100(TM)' Award 2
... much more than what meets the eye, thought to be ...lead to abusive and unbecoming behavior, akin to a...o measure the impact of steroid abuse on patients,...er than just violent behavior. According to ...
...s conducted to gauge the nature of school based se...und that mere abstinence based approaches did not ...feel that youngsters in schools need to know much ...ile a priority of the federal government, are supp...
...most 11 percent rise in the number of tuberculosis...ani and //Bangladeshi communities, latest official...ong patients who were born outside Britain - from ... Agency, said: "The largest increase was seen amon...
...d of Health has asked fast-food restaurants to li...u. It is not a difficult thing to do//. McDonald's...s of various items offered by them, on its Web sit...resisting the idea. It is a change to be welcomed ...
...ted States, 23.5 million children travel billions ...r for Injury Research and Policy (CIRP) at Columbu...onal sample to describe nonfatal school bus-relate...er issue of Pediatrics, from 2001 through 2003 the...
... after hours with a nurse or primary care physicia...s more difficult than in several other countries//...urvey of over 6,000 physicians in seven countries ...ited Kingdom, 76 percent in Germany and 47 percent...
Other Medicine News:Health News:TB Cases On The Rise Among British Asians 2Health News:Nonfatal School Bus-Related Injuries To Children More Common Than Previously Thought 2Health News:Health Care in America-Not a Rosy Picture 2
McCullough Utility Forceps - Smooth
Azar Straight Utility Forceps
Machat Forceps
Bishop-Harmon Curved Tissue Forceps
Medicine Products: